Loading organizations...
§ Private Profile · Spitalfields, Essex, United Kingdom
AI platform for agricultural biotechnology decoding crop genetics to identify gene-editing targets for global seed companies.
Based in London, England, Biographica develops an AI-driven machine learning platform that decodes crop genetics to identify high-value gene-editing targets for traits like yield, disease resistance, and climate resilience. The company operates a B2B model, providing agricultural biotechnology firms and global seed developers with predictive discovery tools that reduce the time and costs associated with traditional crop trait development. Biographica has established strategic partnerships and pilot programs across North America, Europe, and Asia, working alongside notable industry players such as BASF Nunhems and Cibus. To support its ongoing commercial expansion and the opening of a new validation laboratory at Rothamsted Research, the enterprise raised £7 million ($9.5 million) in seed funding led by Faber Ventures, with participation from SuperSeed and Cardumen Capital. Biographica was officially founded in 2022 by co-founders Cecily Price and Dominic Hall.
Biographica has raised $9.4M across 1 funding round.
Biographica has raised $9.4M in total across 1 funding round.
Biographica has raised $9.4M across 1 funding round. Most recently, it raised $9.4M Seed in January 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 7, 2026 | $9.4M Seed | Sofia Santos | Cardumen Capital, Chalfen Ventures, Entrepreneur First, SuperSeed, The Helm | Announced |
Biographica has raised $9.4M in total across 1 funding round.
Biographica's investors include Sofia Santos, Cardumen Capital, Chalfen Ventures, Entrepreneur First, SuperSeed, The Helm.